Role of biochemical markers in the monitoring of COVID-19 patients

Journal of Medical Biochemistry

Riquelme Ismael¹  Guzmán Neftalí²  Morales Pablo²  Riffo Alejandra²  Letelier Pablo²  Encina Nicole²  Silva Halett² 

[1] Universidad Autónoma de Chile, Facultad de Ciencias de la Salud, Instituto de Ciencias Biomédicas, Chile;Universidad Católica de Temuco, Facultad de Ciencias de la Salud, Departamento de Procesos Diagnósticos y Evaluación, Precision Health Research Laboratory, Temuco, Chile;

关键词: coronavirus disease;    covid-19;    sars-cov2;    laboratory diagnosis;    biomarkers;   

DOI  :  10.5937/jomb0-29341

来源: DOAJ

【 摘 要 】

COVID-19 is an infectious disease caused by the SARSCoV-2 virus, which has given rise to a global sanitary emergency. The clinical characteristics of COVID-19 are varied and can range from an asymptomatic infection to a mild to severe pneumonia. Recent studies have shown that different laboratory parameters become altered in these patients, and as such are useful as biomarkers to assess the progression of the disease and categorize patients that may present a severe and/or fatal clinical condition. This review analyzes biochemical and immunological markers that become altered in COVID-19 patients and their impact on different organs at a hepatic, cardiac, renal and pancreatic level, as well as markers of inflammation, analyzing their implications in the evolution of the disease.

【 授权许可】

Unknown